Akebia Therapeutics, Inc. (AKBA)

1.44 +0.07 (+5.11%) USD  |  NASDAQ  |  Jan 22, 16:00
1.45 +0.01 (+0.69%) After-Hours: 20:00
More

Akebia Therapeutics Extraordinary Items, Income Statement (Quarterly)

Extraordinary Items, Income Statement (Quarterly) Chart

View Extraordinary Items, Income Statement (Quarterly) for AKBA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Extraordinary Items, Income Statement (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years

View Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Extraordinary Items, Income Statement (Quarterly) Benchmarks

View Extraordinary Items, Income Statement (Quarterly) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Pfizer Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Zevra Therapeutics, Inc. Upgrade
Organon & Co. Upgrade